BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 28944155)

  • 1. Choroidal neovascular membrane in intraocular tuberculosis.
    Tripathy K
    GMS Ophthalmol Cases; 2017; 7():Doc24. PubMed ID: 28944155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal Bevacizumab for Choroidal Neovascular Membrane at the Edge of a Healed Choroidal Tuberculoma.
    Tripathy K; Chawla R; Sharma YR
    Ocul Immunol Inflamm; 2018; 26(2):239-241. PubMed ID: 27541084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intravitreal connective tissue growth factor neutralizing antibody on choroidal neovascular membrane-associated subretinal fibrosis.
    Daftarian N; Rohani S; Kanavi MR; Suri F; Mirrahimi M; Hafezi-Moghadam A; Soheili ZS; Ahmadieh H
    Exp Eye Res; 2019 Jul; 184():286-295. PubMed ID: 31029789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory choroidal neovascular membrane after healed tuberculous choroidal granuloma.
    Lodhi SA; Saifuddin K; Devulapally S
    GMS Ophthalmol Cases; 2017; 7():Doc06. PubMed ID: 28293535
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravitreal Anti-Vascular Endothelial Growth Factor and Moxifloxacin for Treatment of Tubercular Choroidal Granuloma and Sub retinal Abscess.
    Manoharan A; Mohan S; Raman R; Biswas J
    Ocul Immunol Inflamm; 2023 Jan; ():1-5. PubMed ID: 36637985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal bevacizumab in the management of choroidal neovascular membrane secondary to choroidal osteoma.
    Narayanan R; Shah VA
    Eur J Ophthalmol; 2008; 18(3):466-8. PubMed ID: 18465736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Choroideremia associated with choroidal neovascularization treated with intravitreal bevacizumab.
    Palejwala NV; Lauer AK; Weleber RG
    Clin Ophthalmol; 2014; 8():1675-9. PubMed ID: 25214760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiopathic Peripapillary Subretinal Neovascular Membrane in a Young Woman with Recurrence of the Lesion during Pregnancy after Treatment with Intravitreal Bevacizumab.
    Al-Gharbi N; Al Abdulsalam O; Al Habash A
    Middle East Afr J Ophthalmol; 2015; 22(2):245-8. PubMed ID: 25949086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. INFLAMMATORY CHOROIDAL NEOVASCULAR MEMBRANE: Long-Term Visual and Anatomical Outcomes After Intravitreal Anti-vascular Endothelial Growth Factor Therapy.
    Dʼsouza P; Ranjan R; Babu U; Kanakath AV; Saravanan VR
    Retina; 2018 Jul; 38(7):1307-1315. PubMed ID: 28520642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in Visual Outcome to Anti-Vascular Endothelial Growth Factors in Choroidal Neovascular Membrane Developing in Eyes with Previously Untreated Versus Focal Laser-Treated Central Serous Chorioretinopathy.
    Roy R; Saurabh K; Das D; Panigrahi PK; Das S; Pal SS; Jain A
    Semin Ophthalmol; 2017; 32(6):781-786. PubMed ID: 27533737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Choroidal Neovascular Membranes Associated with Choroidal Nevi.
    Munie MT; Demirci H
    Ophthalmol Retina; 2018 Jan; 2(1):53-58. PubMed ID: 31047303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial swept-source optical coherence tomography: Tale of a choroidal tuberculoma.
    Mistry S; Majumder PD; Biswas J
    Oman J Ophthalmol; 2019; 12(1):42-45. PubMed ID: 30787534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal bevacizumab (avastin) and ranibizumab (lucentis) for choroidal neovascularization overlying choroidal osteoma.
    Shields CL; Salazar PF; Demirci H; Benson WE; Shields JA
    Retin Cases Brief Rep; 2008; 2(1):18-20. PubMed ID: 25389607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The other CNVM: a review of myopic choroidal neovascularization treatment in the age of anti-vascular endothelial growth factor agents.
    Adatia FA; Luong M; Munro M; Tufail A
    Surv Ophthalmol; 2015; 60(3):204-15. PubMed ID: 25890624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal bevacizumab in the management of posttraumatic choroidal neovascular membrane.
    Rishi P; Shroff D; Rishi E
    Retin Cases Brief Rep; 2008; 2(3):236-8. PubMed ID: 25390097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resolution of Large Choroidal Tuberculoma following Monotherapy with Intravitreal Ranibizumab.
    Jain S; Agarwal A; Gupta V
    Ocul Immunol Inflamm; 2020 Apr; 28(3):494-497. PubMed ID: 30986122
    [No Abstract]   [Full Text] [Related]  

  • 17. Optic nerve head tubercular granuloma successfully treated with anti-VEGF intravitreal injections in addition to systemic therapy.
    Invernizzi A; Franzetti F; Viola F; Meroni L; Staurenghi G
    Eur J Ophthalmol; 2015; 25(3):270-2. PubMed ID: 25363855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic Choroidal Neovascular Membrane in Choroideremia Treated With Intravitreal Bevacizumab.
    Chen RC; Traboulsi EI; Rachitskaya A
    Ophthalmic Surg Lasers Imaging Retina; 2019 Jun; 50(6):e188-e192. PubMed ID: 31233164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary Acquired Toxoplasma Retinochoroiditis: Choroidal Neovascular Membrane as an Early Complication.
    Mushtaq F; Ahmad A; Qambar F; Ahmad A; Zehra N
    Cureus; 2019 Feb; 11(2):e4001. PubMed ID: 30989010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral choroidal neovascular membrane in a case of peripheral exudative hemorrhagic chorioretinopathy managed with combination therapy.
    Takkar B; Roy S; Sodhi PK; Azad S; Bajwa GS
    Int Ophthalmol; 2017 Apr; 37(2):429-431. PubMed ID: 27312539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.